| |
 

Regulation of the Promotion of Prescription Drugs (DDMAC Update)

March 16, 2011

Executive Summary

Pharmaceutical companies are required by law to submit to the FDA promotional materials that they are preparing to disseminate by print or broadcast. Watch Bryant Godfrey, Regulatory Counsel, Division of Drug Marketing, Advertising and Communications, Food and Drug Administration discuss what is called a “risk-based” approach to enforcing the FDA’s regulatory policies.

View video below.



Source

"Regulation of the Promotion of Prescription Drugs (DDMAC Update)." Bryant Godfrey, Regulatory Counsel, Division of Drug Marketing, Advertising and Communications, Food and Drug Administration. ANA Advertising Law and Public Policy Conference, 03/16/11.

You must be logged in to submit a comment.

Relevant Topics